The Patent Finder

Sutro Biopharma, Inc.

45 patents currently held · Updated Nov 17, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 3 name spellings.

0
Ending by 2030
Sep 2031
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 11, 2026
    The maintenance fee for High Growth Capacity Auxotrophic Escherichia Coli and Methods of Use (US 10,316,322) comes due Dec 11, 2026. Unpaid by Jun 11, 2027, it lapses early.
  • 1 fee due Jan 25, 2027
    The maintenance fee for ANTI-CD74 Antibody Conjugates, Compositions Comprising ANTI-CD74 Antibody Conjugates and Methods of Using ANTI-CD74 Antibody Conjugates (US 11,708,413) comes due Jan 25, 2027. Unpaid by Jul 26, 2027, it lapses early.
  • 1 fee due Mar 5, 2027
    The maintenance fee for Immunomodulator Antibody Drug Conjugates and Uses Thereof (US 11,744,876) comes due Mar 5, 2027. Unpaid by Sep 7, 2027, it lapses early.
  • 2 fees due Apr 17 to 22, 2027 · next Apr 17
  • 1 fee due May 26, 2027
    The maintenance fee for Codon optimization for titer and fidelity improvement (US 10,487,133) comes due May 26, 2027. Unpaid by Nov 26, 2027, it lapses early.
  • 1 fee due Jun 10, 2027
    The maintenance fee for Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use (US 10,501,558) comes due Jun 10, 2027. Unpaid by Dec 10, 2027, it lapses early.
  • 1 fee due Jul 9, 2027
    The maintenance fee for Hemiasterlin Derivatives for Conjugation and Therapy (US 11,866,515) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
  • 1 fee due Sep 24, 2027
    The maintenance fee for Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates (US 10,596,270) comes due Sep 24, 2027. Unpaid by Mar 24, 2028, it lapses early.
  • 1 fee due Oct 16, 2027
    The maintenance fee for Antibodies Comprising Site-Specific Non-Natural Amino Acid Residues, Methods of Their Preparation and Methods of Their Use (US 11,958,909) comes due Oct 16, 2027. Unpaid by Apr 17, 2028, it lapses early.
  • 1 fee due Nov 12, 2027
    The maintenance fee for Formulations for drying bacterial cell extracts (US 10,648,010) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,040,253A method for enhancing recombinant protein production by cell-free protein expression system.
In force
 · High confidence
In forceHigh confidence
US 10,669,347Antibodies Comprising Site-Specific Non-Natural Amino Acid Residues, Methods of Their Preparation and Methods of Their Use
In force
 · High confidence
In forceHigh confidence
US 11,958,909Antibodies Comprising Site-Specific Non-Natural Amino Acid Residues, Methods of Their Preparation and Methods of Their Use
In force
 · High confidence
In forceHigh confidence
US 10,501,558Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,682,934Modified amino acids
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,994,527Modified amino acids
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,112,900Modified amino acids
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,730,837Modified amino acids
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,738,724Antibodies Comprising Site-Specific Non-Natural Amino Acid Residues, Methods of Their Preparation and Methods of Their Use
In force
 · High confidence
In forceHigh confidence
US 9,650,621Proteolytic inactivation of select proteins in bacterial extracts for improved expression
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 45 patents shown.
Pro members see all 45.
Pro members: see all 45 patents
Also on record, not counted in the 45: 1 patent in force now held by others · 11 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

17 pending · 3 abandoned · 25 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited